Mixed Topics
Conference Coverage
CMML: GM-CSF inhibitor lenzilumab shows early promise
The PREACH-M trial has yielded encouraging preliminary results in treating CMML, a rare, “insidious” leukemia that can transform into AML.
News
Aspirin warning: Anemia may increase with daily use
“We found that low-dose aspirin also increased the risk of anemia during the trial, and this was most likely due to bleeding that was not...
Latest News
Docs misdiagnose aneurysm and patient dies; must pay $29M; more
“If you just treat people based on what the likelihood is, statistically, you’re going to miss a lot of life-threatening conditions.”
Latest News
ChatGPT in medicine: The good, the bad, and the unknown
Three-expert panel at DDW suggests clinicians should embrace the technology.
Conference Coverage
PV: Novel rusfertide shows ‘impressive’ efficacy
The novel synthetic form of liver hormone hepcidin represents a “paradigm shift” in polycythemia vera treatment, allowing patients to avoid the...
News
FDA warns of tattoo ink tied to dangerous infections
“I’ve seen several different infections from tattooing, and they are from organisms that tend to contaminate things in damp, liquid-type...
Conference Coverage
PCOS associated with shorter lifespan
“I think we need to acknowledge that this is a health burden and not just a reproductive problem.”
Conference Coverage
Cancer drug shortages spur worry, rationing, and tough choices
Limited supplies of crucial medications are disrupting patient care, oncologists say.
Conference Coverage
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology
A pair of new studies show that drugs can reduce cancer risk when cells are elusive.
Latest News
‘New standard of care’ for capecitabine hand-foot syndrome
“For me as a GI oncologist, topical diclofenac for prevention of HFS for patients on capecitabine is practice changing,” ...